The evidence for voluntary unpaid donation

The World Health Organization has recommended voluntary unpaid blood donation as the safest model since 1975, and the evidence supporting this position has only strengthened since. Research consistently shows that paid donation systems carry higher rates of blood-borne infections in the donated supply. When donors are financially motivated, the incentive to donate even when ineligible increases, and the likelihood of honest disclosure on health questionnaires decreases.

Voluntary donors, by contrast, donate specifically to help others with nothing material to gain. Studies have found meaningfully lower prevalence of HIV, hepatitis B and hepatitis C in voluntary donor populations compared to paid systems. The UK's decision to maintain a purely voluntary model is not sentiment, it is evidence-based public health policy.

What donors actually receive

After donating, every donor receives a drink and a snack in the refreshment area. The NHS typically provides biscuits, crisps, juice and water. This is provided for practical post-donation recovery purposes, not as a token of payment. The snack and drink help stabilise blood sugar and support fluid replacement in the 15 to 30 minutes after donation.

Some NHS blood donor centres also send thank-you communications tracking cumulative donation milestones. Long-standing regular donors may receive recognition of their contribution, such as certificates or small branded items at significant milestones. None of these constitute payment and none have significant monetary value.

Plasma for medicines: a separate question

A distinction exists between NHS plasma donation for direct patient transfusion and plasma collection for commercial pharmaceutical manufacture. The latter involves processing large volumes of plasma into products such as immunoglobulins, clotting factors and albumin. Some private plasma collection companies operating in the UK offer payment for this type of donation.

This is separate from NHS Blood and Transplant and from the blood donation most people think of when they ask this question. NHS donation of whole blood, platelets and plasma for direct transfusion remains entirely unpaid. The debate around paid plasma for pharmaceutical use is ongoing in the UK but relates to a different part of the system.

How the voluntary model protects the blood supply

The practical mechanism by which voluntarism improves safety is straightforward. A person who has nothing to gain financially from donating and who knows their donation will go to a stranger in need has no reason to withhold information about their health, recent behaviour or medical history. They attend because they want to help, and they disclose honestly because they understand that dishonest disclosure could harm someone vulnerable.

Paid donors, particularly those in financial difficulty, face a different incentive structure. The prospect of payment can outweigh the motivation to disclose a deferral-triggering condition or behaviour. This dynamic has been documented in multiple international studies and is the primary reason the WHO and most high-income countries maintain voluntary systems.

International comparisons

The United States permits payment for plasma donation and operates a largely paid plasma collection industry. Most of Western Europe, Canada, Australia and Japan maintain voluntary unpaid donation for whole blood. The UK has resisted calls to introduce paid plasma donation for pharmaceutical manufacture on the grounds that any financial incentive for donation risks undermining the cultural norm of voluntary giving that underpins the safety of the entire system.

Countries that have shifted from paid to voluntary models have consistently seen improvements in donation safety. The UK's position is informed by this international evidence and is regularly reviewed as the global picture evolves.